UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Job strain and risk of acute recurrent coronary heart disease events

JAMA : the journal of the American Medical Association, 2007-10, Vol.298 (14), p.1652

2007

Volltextzugriff (PDF)

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

Biological psychiatry (1969), 2007-08, Vol.62 (4), p.302-308

2007

Volltextzugriff (PDF)

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

Circulation (New York, N.Y.), 1999-06, Vol.99 (25), p.3227-3233

1999

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Circulation (New York, N.Y.), 1999-11, Vol.100 (20), p.2045-2048

1999

Volltextzugriff (PDF)

Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment―Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies

Circulation (New York, N.Y.), 2009-06, Vol.119 (24), p.3101-3109

2009

Volltextzugriff (PDF)

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

European heart journal. Acute cardiovascular care, 2014-03, Vol.3 (1), p.37-45

2014

Volltextzugriff (PDF)

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Circulation (New York, N.Y.), 2001-06, Vol.103 (25), p.3069-3074

2001

Volltextzugriff (PDF)

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

Circulation (New York, N.Y.), 1998-01, Vol.97 (3), p.251-256

1998

Volltextzugriff (PDF)

Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin

Psychosomatic medicine, 2006-03, Vol.68 (2), p.187-200

2006

Volltextzugriff (PDF)

Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug

Journal of the American College of Cardiology, 2005-08, Vol.46 (4), p.638-645

2005

Volltextzugriff (PDF)

Depression and 1-year prognosis in unstable angina

Archives of internal medicine (1960), 2000-05, Vol.160 (9), p.1354

2000

Volltextzugriff (PDF)

Previous aspirin use may attenuate the severity of the manifestation of acute Ischemic syndromes

Circulation (New York, N.Y.), 1995-10, Vol.92 (7), p.1743-1748

1995

Volltextzugriff (PDF)

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina : The Canadian lamifiban study

Circulation (New York, N.Y.), 1996-09, Vol.94 (5), p.899-905

1996

Volltextzugriff (PDF)

Aspirin, heparin, or both to treat acute unstable angina

The New England journal of medicine, 1988-10, Vol.319 (17), p.1105-1111

1988

Volltextzugriff (PDF)

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial

The Journal of thoracic and cardiovascular surgery, 2003-09, Vol.126 (3), p.807-813

2003

Volltextzugriff (PDF)

Left ventricular ejection fraction to predict early mortality in patients with non–ST-segment elevation acute coronary syndromes

The American heart journal, 2005-08, Vol.150 (2), p.215-220

2005

Volltextzugriff (PDF)

Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study

Journal of the American College of Cardiology, 1999-04, Vol.33 (5), p.1353-1361

1999

Volltextzugriff (PDF)

Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional : Regimens Results From the PREPAIR Randomized Study

Journal of the American College of Cardiology, 2008-03, Vol.51 (11), p.1066-1072

2008

Volltextzugriff (PDF)

Genetic predictors of depressive symptoms in cardiac patients

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2009-04, Vol.150B (3), p.381-388

2009

Volltextzugriff (PDF)

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial

The American heart journal, 2015-05, Vol.169 (5), p.622-630.e6

2015

Volltextzugriff (PDF)

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

The American heart journal, 2012-07, Vol.164 (1), p.43-51

2012

Volltextzugriff (PDF)

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction : results from the CARDINAL study

European heart journal, 2006-06, Vol.27 (11), p.1289-1297

2006

Volltextzugriff (PDF)

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy

International journal of cardiology, 2013-10, Vol.168 (3), p.2127-2133

2013

Volltextzugriff (PDF)

Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification

Canadian journal of cardiology, 2009-07, Vol.25 (7), p.e225-e231

2009

Volltextzugriff (PDF)

Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty

Circulation (New York, N.Y.), 2000-03, Vol.101 (9), p.955-961

2000

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Aktive Filter

ThemaMyocardial Infarction - Drug Therapy

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(114)

Sprache

Englisch
(114)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Job strain and risk of acute recurrent coronary heart disease events

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment―Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin

Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug

Depression and 1-year prognosis in unstable angina

Previous aspirin use may attenuate the severity of the manifestation of acute Ischemic syndromes

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina : The Canadian lamifiban study

Aspirin, heparin, or both to treat acute unstable angina

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial

Left ventricular ejection fraction to predict early mortality in patients with non–ST-segment elevation acute coronary syndromes

Geometric features of coronary artery lesions favoring acute occlusion and myocardial infarction: a quantitative angiographic study

Clopidogrel 600-Mg Double Loading Dose Achieves Stronger Platelet Inhibition Than Conventional : Regimens Results From the PREPAIR Randomized Study

Genetic predictors of depressive symptoms in cardiac patients

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction : results from the CARDINAL study

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy

Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification

Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty

Aktive Filter

Suchergebnisse filtern